---
authors:
- Barry, Henry C
category: Clinical Review
clinical_significance: High
external_resources:
- title: PubMed Entry
  type: reference
  url: https://pubmed.ncbi.nlm.nih.gov/37983713/
file_path: 2023/11/adipose-derived-stem-cell-injections-provide-borderline-mean.md
issue: '5'
keywords:
- Pain
- Humans
- Knee Joint
- Adult
- Stem Cells
- Injections, Intra-Articular
- Treatment Outcome
- Injections
- Osteoarthritis, Knee
last_updated: '2025-07-30'
mesh_terms:
- Humans
- Adult
- Knee Joint
- Osteoarthritis, Knee
- Injections
- Pain
- Stem Cells
- Injections, Intra-Articular
- Treatment Outcome
original_format: PubMed
pages: Online
patient_population: Adults
peer_reviewed: true
pmid: '37983713'
processed_date: '2025-07-30'
publication_date: '2023-11-01'
pubmed_enriched: true
pubmed_enriched_date: '2025-07-30'
reading_time_minutes: 5
source: American family physician
specialty:
- Family Medicine
status: processed
tags:
- clinical-review
- family-practice
- clinical-medicine
- pubmed-enhanced
title: Adipose-Derived Stem Cell Injections Provide Borderline Meaningful Pain Relief in Adults With Degenerative Joint Disease
  of the Knee.
topics:
- Family Medicine
volume: '108'
---

# Adipose-Derived Stem Cell Injections Provide Borderline Meaningful Pain Relief in Adults With Degenerative Joint Disease of the Knee.

**Authors:** Barry, Henry C

**Published in:** American family physician | Vol. 108, No. 5 | 2023-11-01

**Links:** [PubMed](https://pubmed.ncbi.nlm.nih.gov/37983713/)

## Clinical Information

**Population:** Adults | **Clinical Significance:** High

## Topics & Specialties

**Specialties:** Family Medicine

**Topics:** Family Medicine

## MeSH Terms

Humans, Adult, Knee Joint, Osteoarthritis, Knee, Injections, Pain, Stem Cells, Injections, Intra-Articular, Treatment Outcome

## Article Content

*Full article content to be extracted and formatted from source material.*

## Additional Resources

- [PubMed Entry](https://pubmed.ncbi.nlm.nih.gov/37983713/) (reference)

---

*Processed: 2025-07-30* | *PubMed Enhanced: 2025-07-30*
